Healthcare Costs and Resource Utilization in Aimovig Migraine Patients: a Retrospective Study Using United States Claims Data
NCT05177406 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1839
Last updated 2022-01-04
Summary
The proposed study is a retrospective, non-interventional analysis that uses medical and pharmacy claims data in the US from Komodo Health
Conditions
Interventions
- OTHER
-
Aimovig
patients newly initiating Aimovig therapy
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-31
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- United States
Study Locations
More Related Trials
-
Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine
NCT06412965 ·Status: COMPLETED
-
Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications
NCT05518123 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
NCT05156398 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
NCT05125302 ·Status: RECRUITING ·Phase: PHASE3
-
Neurostimulation Device for Treatment of Migraine Headache
NCT01630044 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of SOM230 s.c. in Cluster Headache
NCT02619617 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants
NCT04492020 ·Status: COMPLETED ·Phase: PHASE3
-
Facilitating Migraine Medication Adherence and Optimizing Medication Use
NCT02473692 ·Status: WITHDRAWN
-
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
NCT06810505 ·Status: RECRUITING ·Phase: PHASE3
-
Trial of Comprehensive Migraine Intervention
NCT01071317 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
NCT05707949 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Phase 3 Study of MAP0004 in Adult Migraineurs
NCT00623636 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY3451838 in Participants With Migraine
NCT04498910 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.
NCT02174861 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study Of Migraine Evolution
NCT00460005 ·Status: COMPLETED
-
An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine
NCT03934086 ·Status: NO_LONGER_AVAILABLE
-
AMG 334 20160172 Pediatric Migraine PK Study.
NCT03499119 ·Status: COMPLETED ·Phase: PHASE1
-
A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine
NCT04686136 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
NCT06543914 ·Status: RECRUITING
-
Standardized sTudy With Almotriptan in eaRly Treatment of Migraine
NCT00725140 ·Status: COMPLETED
-
The Utility of Telemedicine in the Management of Migraine
NCT01706003 ·Status: COMPLETED
-
A Study of Gastric Delay in Migraine Patients (3207-003)
NCT00548353 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)
NCT05127954 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
NCT05711394 ·Status: RECRUITING ·Phase: PHASE3
-
A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache
NCT01946126 ·Status: COMPLETED